Teva Pharmaceutical Industries Ltd. has launched amlodipine/valsartan/hydrochlorothiazide tablets, a hypertension medication, in the United States. Teva said Monday that its product is a generic equivalent of Exforge HCT tablets from Novartis.
PepsiCo make has made a pair of key executive appointments for its global operations. The food and beverage giant said Monday that Enderson Guimaraes, currently chief executive officer of PepsiCo Europe, has been named executive vice president of global categories and operations for PepsiCo.
Jelly Belly Candy Co. has introduced Draft Beer Jelly Bean Bottles in their own point-of-purchase display. Jelly Belly said Tuesday that the miniature plastic bottle is filled with 1.5 ounces of the Jelly Belly Draft Beer jelly beans, which made their debut this past spring.
Endo International plc has purchased the rights to Natesto testosterone nasal gel from Trimel BioPharma SRL, a subsidiary of Trimel Pharmaceuticals Corp.
David Heist, director of industry affairs and customer relations at Bayer Consumer Care, has announced his retirement. In an e-mail message to industry colleagues on Monday, Heist said he plans to retire from Bayer on May 1, 2015. He has served in his current position at Bayer for 20 years.
Perrigo Co. plc has launched an authorized generic version of Protopic Ointment 0.1% and 0.03%. Perrigo said Monday that it has begun shipping its generic product to pharmacies. Protopic Ointment (tacrolimus), from Astellas U.S. LLC, is indicated for the treatment of moderate to severe eczema.
McKesson Corp. and Omnicare Inc. have expanded their distribution pact to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. The companies said Monday that the new five-year distribution agreement extends to December 2019.
Cardinal Health Inc. has entered a long-term agreement in which it will consolidate its physician office commercial organization into the medical group of health care supplier Henry Schein Inc.
Purdue Pharma L.P. has received approval from the Food and Drug Administration for Hysingla ER (hydrocodone bitartrate) extended-release tablets CII, an opioid pain reliever.
Jim Norred has been appointed as president of the Marketing Solutions Group at Crossmark. Jim Norred The sales and marketing firm said Thursday that Norred will lead a group that provides insight-driven marketing solutions to address the day-to-day challenges that brands experience.
Dr. Reddy’s Laboratories has announced the U.S. rollout of over-the-counter fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets 60 mg/120 mg, a cold/allergy medication. Dr.
SensatioNail has signed actress Gabrielle Union as its first celebrity brand ambassador and creative advisor.
Moberg Pharma AB has named Jeff Vernimb as general manager of its U.S. operations. The Sweden-based pharmaceutical company said Thursday that Vernimb’s appointment, effective Dec. 15, also makes him a member of Moberg’s management team.
Amneal Pharmaceuticals LLC has launed Lopreeza tablets (estradiol/norethindrone acetate), a menopause medication, in 0.5 mg/0.1 mg and 1 mg/0.5 mg strengths.
Matrixx Initiatives Inc. has introduced Zicam Kids, a homeopathic cold medicine designed to provide symptom relief for children ages 6 to 11.
PrescribeWellness Takes Steps to Ensure Medication Synchronization Tools Are Available to All of Its Pharmacy Customers November 18, 2014 09:06 AM Eastern Standard Time ALISO VIEJO, Calif.
